Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Chemoimmunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06267144
What this trial is testing

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 20
Not applicableNot Yet RecruitingNCT07506889
What this trial is testing

Simplified Exercise-based Risk Assessment in Lung Cancer

Who this might be right for
Lung Cancer (Diagnosis)LobectomySurgery Complications+3 more
Linkoeping University 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07617389
What this trial is testing

Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study)

Who this might be right for
Stage IIA-IIIB NSCLCSelective Mediastinal Lymph Node SamplingSystematic medIastinal Lymph Node Dissection
Wen-zhao ZHONG 358
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07549906
What this trial is testing

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Who this might be right for
Colon Cancer (Stage II &Amp; III)ImmunotherapyBeta Blocker+1 more
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06509568
What this trial is testing

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 92
Very early researchNot Yet RecruitingNCT07028918
What this trial is testing

A Prospective Single-Arm Study（NCLDR）

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Qilu Hospital of Shandong University 35
Testing effectiveness (Phase 2)Ended earlyNCT02345772
What this trial is testing

Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy

Who this might be right for
HER2-positive Breast CancerER-positive Breast Cancer
Western Regional Medical Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT06623656
What this trial is testing

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Weill Medical College of Cornell University 112
Not applicableLooking for participantsNCT07528066
What this trial is testing

Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC

Who this might be right for
Neoadjuvant ChemoimmunotherapyRobotic Pulmonary ResectionStage IIB-III NSCLC
Shanghai Chest Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT05503667
What this trial is testing

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Stage IIILung Adenocarcinoma Stage IVEGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China 96
Testing effectiveness (Phase 2)Looking for participantsNCT07121374
What this trial is testing

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

Who this might be right for
Pleural Epithelioid MesotheliomaMesothelioma; PleuraNeoadjuvant Chemoimmunotherapy
University Hospital, Antwerp 37
Large-scale testing (Phase 3)Not Yet RecruitingNCT07608159
What this trial is testing

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Who this might be right for
Non Small Cell Lung CancerStereotactic Body RadiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Shanghai Pulmonary Hospital, Shanghai, China 201
Not applicableUnknownNCT06394427
What this trial is testing

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage ⅢANon-small Cell Lung Cancer Stage IIIB
West China Hospital 250
Not applicableLooking for participantsNCT07559123
What this trial is testing

Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE

Who this might be right for
NSCLCNeoadjuvant ChemoimmunotherapyCT
Samsung Medical Center 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605535
What this trial is testing

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialOvarian CancerFallopian Tube Neoplasms+2 more
CanariaBio Inc. 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743632
What this trial is testing

Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Kansas Medical Center 110
Testing effectiveness (Phase 2)Looking for participantsNCT07468630
What this trial is testing

Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

Who this might be right for
Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT05645380
What this trial is testing

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Who this might be right for
Triple Negative Breast CancerBreast Cancer
University of Kansas Medical Center 139
Not applicableActive Not RecruitingNCT05459415
What this trial is testing

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNeoadjuvant TherapyResection Margin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 54
Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40
Next Page